Abstract
Neurodegenerative diseases are among the greatest strategic challenges associated with increased life expectancy and changes in the demographic profile worldwide. Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most frequent neurodegenerative diseases, affecting 13% of the population over 65 years old. In Brazil, the Ministry of Health projects that by 2050 this percenta…